Two drug manufacturers and a trade group representing group purchasing organizations are pushing back against a recent request by House Democrats for Congress' investigative arm to probe the relationship between drug compounding, drug shortages and GPOs.
Source found here. Subscription required.
No comments:
Post a Comment